The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 14, 2026
Filed:
Oct. 12, 2020
Applicant:
Gannex Pharma Co., Ltd., Shanghai, CN;
Inventors:
Bailing Yang, Shanghai, CN;
Gudmundsson Kristjan, Shanghai, CN;
Liuyu Dong, Shanghai, CN;
James Chen, Shanghai, CN;
Assignee:
Gannex Pharma Co. Ltd., Shanghai, CN;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 413/12 (2006.01); A61K 31/42 (2006.01); A61K 31/427 (2006.01); A61K 31/4439 (2006.01); A61K 31/496 (2006.01); A61K 31/501 (2006.01); A61K 45/06 (2006.01); A61P 1/16 (2006.01); A61P 31/20 (2006.01); C07D 261/08 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 413/12 (2013.01); A61K 31/42 (2013.01); A61K 31/427 (2013.01); A61K 31/4439 (2013.01); A61K 31/496 (2013.01); A61K 31/501 (2013.01); A61K 45/06 (2013.01); A61P 1/16 (2018.01); A61P 31/20 (2018.01); C07D 261/08 (2013.01); C07D 417/12 (2013.01);
Abstract
Provided are a compound for modulating the activity of FXR having a structure of formula (I), a pharmaceutically acceptable salt, an ester or a stereoisomer thereof.